By Neyret Group
Neyret Group showing inhalation medical device assembly capabilities at DDL conference
Chaponost, France: – Leading manufacturer of customized automatic assembly and test machinery for the medical and life sciences industries Neyret Group will make its debut as an exhibitor and sponsor at the Drug Delivery to the Lungs (DDL) Conference in the Scottish capital of Edinburgh.
The Neyret Group stand at Booth 110 at the Edinburgh International Conference Centre will present its advanced capabilities in automated indexed and continuous motion assembly lines as applied to high-speed production of aerosols and medical devices for inhalation applications.
High speed medical device assembly
The stand displays will include videos showcasing assembly machines and samples of assembled products, such as pMD inhalers, involving multiple steps at a production rate of 3600-7200 products per hour.
The displays will also show how video inspection can be integrated into the assembly processes.
Neyret Group CEO Bruno Neyret commented: “This is our first-time attendance as an exhibiting sponsor at this valuable conference, which will provide us with an excellent platform for sharing our expertise in high precision assembly of aerosols and medical devices with companies looking for a reliable supplier of automated assembly lines.”
About Neyret Group
French-based Neyret Group, with a worldwide presence, designs and manufactures customized automatic assembly and test machines for the medical and life sciences industries.
The company produces indexed motion and continuous motion assembly, test and print machines that are fully customized to customer’s ideal requirements.
Neyret Group employs more than 270 people at three production sites: in France with Société Guy Neyret producing indexed machines in Chaponost, near Lyon, and Lagniel, producing continuous motion machines in Douvres-la-Délivrande near Caen, Normandy; and in the United States with Franklin Automation producing indexed machines in Sugar Grove, Illinois.
Further information at: https://www.neyretgroup.com/en
About DDL 2023
The Drug Delivery to the Lungs (DDL) Conference (DDL) is the Premier International Pulmonary and Nasal Drug Delivery Conferences, providing an annual forum for scientists, academics, clinicians, regulatory and industry specialists involved in developing medicines for inhalation.
The 34th anniversary meeting, DDL 2023, is a three-day event opening December 6, again at the Edinburgh International Conference Center at The Exchange close to University of Edinburgh.
The 2023 conference will feature five themed sessions each with a combination of invited and submitted lectures given by experts in the field of inhalation and students working to advance respiratory science. Major themes will include digital technologies, novel formulations and processes, emerging therapeutics, and future challenges.
The event is organized by The Aerosol Society, with more information at: https://ddl-conference.com/
Resources
Click on Neyret technology medical and pharma applications for more on Neyret Group solutions.